The Board of Directors of Dr. Agarwal's Health Care Limited approved, via circular resolution dated November 19, 2026, the allotment of 1,51,90,373 (One Crore Fifty-One Lakh Ninety Thousand Three Hundred and Seventy-Three) fully paid-up Equity Shares. These shares have a face value of ₹1 each.

The shares were allotted to eligible equity shareholders of Dr. Agarwal's Eye Hospital Limited (the Transferor Company) as on the Record Date of Wednesday, November 18, 2026.

The allotment was made according to the approved Share Exchange Ratio under the Scheme:

  • 23 (Twenty-Three) fully paid-up Equity Shares of face value of ₹1 each of Dr. Agarwal's Health Care Limited
  • For every 2 (Two) fully paid-up Equity Shares of face value of ₹10 each held in Dr. Agarwal's Eye Hospital Limited

The newly allotted Equity Shares will rank pari passu in all respects with the existing Equity Shares of the company.

Capital Structure Impact

Consequent to this allotment, the company's paid-up equity share capital has increased:

  • Pre-allotment: ₹31,70,99,111 consisting of 31,70,99,111 equity shares of ₹1 each
  • Post-allotment: ₹33,22,89,484 (Indian Rupees Thirty Three Crores Twenty Two Lakh Eighty Nine Thousand Four Hundred and Eighty Four) consisting of 33,22,89,484 equity shares of ₹1 each

Additional Scheme Requirement

Pursuant to the Scheme, 35,11,925 equity shares of face value of ₹10 each held by Dr. Agarwal's Health Care Limited in the Transferor Company prior to the effectiveness of the Scheme stand cancelled and extinguished.

Next Steps

The company will take necessary steps to obtain listing and trading approvals for the aforesaid Equity Shares from BSE Limited and National Stock Exchange of India Limited, in terms of Clause 18.5 of the Scheme.

This information has been made available on the company's website at www.dragarwals.co.in.